by Team Small News | May 4, 2025 | Dr Reddy's
The Indian pharmaceutical company, Dr. Reddy’s Laboratories, is facing a challenging time due to regulatory issues surrounding one of its key products, Nimesulide. The Drug Technical Advisory Board (DTAB) and the Central Drugs Standard Control Organization...
by Team Small News | May 2, 2025 | Dr Reddy's
The Indian Council of Medical Research (ICMR) has recommended that all formulations of the painkiller Nimesulide above 100 milligrams should be banned due to its poor safety profile. The recommendation comes after a report by ICMR, which was requested by the Drugs... by Team Small News | Apr 28, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s Laboratories has expanded its partnership with Sanofi Healthcare to introduce a novel drug, Beyfortus, for the prevention of lower respiratory tract disease (LRTD) in newborns and infants. Beyfortus contains the monoclonal antibody nirsevimab and is... by Team Small News | Apr 10, 2025 | Dr Reddy's, Pharma
Hyderabad-based pharmaceutical company, Dr. Reddy’s Laboratories Ltd, has partnered with US-based enterprise technology provider, Kyndryl, to transform its IT operations across all locations, including manufacturing plants, international sites, datacenters,... by Team Small News | Apr 6, 2025 | Dr Reddy's, Pharma
Dr Reddy’s Laboratories Limited, a pharmaceutical company, has received a showcause notice from the Income Tax Department, demanding a massive amount of over Rs 2,395 crore. The notice is related to the merger of Dr Reddy’s Holdings Limited (DRHL) with the... by Team Small News | Apr 2, 2025 | Dr Reddy's, Pharma
The former Dr. Reddy’s Laboratories pharmaceutical manufacturing site in Shreveport, Louisiana, is now up for sale. The 56-acre property, which was once home to 107 employees, was sold to Jaguar Labs Holdings, LLC, an affiliate of Ten Oaks Group. Realtor Chris...